Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Po-Han Lin

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Cancers|October 13, 2021
RAS Mediates BET Inhibitor-Endued Repression of Lymphoma Migration and Prognosticates a Novel Proteomics-Based Subgroup of DLBCL through Its Negative Regulator IQGAP3Chih-Cheng Chen, Chia-Chen Hsu, Sung-Lin Chen, et al.
Steroids|March 22, 2016
Role of testosterone in regulating induction of TNF-α in rat spleen via ERK signaling pathwayChien-Wei Chen, Cai-Yun Jian, Po-Han Lin, et al.
Frontiers in Oncology|December 6, 2021
Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant TherapyPo-Han Lin, Ming-Yang Wang, Chiao Lo, et al.
Scientific Reports|February 2, 2020
Downregulation of testosterone production through luteinizing hormone receptor regulation in male rats exposed to 17α-ethynylestradiolPo-Han Lin, Tsung-Hsien Kuo, Chih-Chieh Chen, et al.
International Journal of Biological Sciences|December 21, 2016
Genes involved in angiogenesis and mTOR pathways are frequently mutated in Asian patients with pancreatic neuroendocrine tumorsWen-Chi Chou, Po-Han Lin, Yi-Chen Yeh, et al.
Journal of Human Genetics|January 27, 2012
Multimodel assessment of BRCA1 mutations in Taiwanese (ethnic Chinese) women with early-onset, bilateral or familial breast cancerWen-Hong Kuo, Po-Han Lin, Ai-Chu Huang, et al.
Journal of Surgical Oncology|September 3, 2013
Clinical and pathologic risk factors of tumor recurrence in patients with node-negative early breast cancer after mastectomyPo-Han Lin, Ming-Hsin Yeh, Liang-Chih Liu, et al.
Cancers|January 20, 2019
Varlitinib Downregulates HER/ERK Signaling and Induces Apoptosis in Triple Negative Breast Cancer CellsChun-Yu Liu, Pei-Yi Chu, Chun-Teng Huang, et al.
Angewandte Chemie (International Ed. in English)|May 23, 2024
Solid-Phase-Supported Chemoenzymatic Synthesis and Analysis of Chondroitin Sulfate Proteoglycan GlycopeptidesPo-Han Lin, Yongmei Xu, Semiha Kevser Bali, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|June 25, 2022
Neoadjuvant afatinib with paclitaxel for triple-negative breast cancer and the molecular characteristics in responders and non-respondersPo-Han Lin, Ling-Ming Tseng, Yi-Hsuan Lee, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Cancers|October 13, 2021
RAS Mediates BET Inhibitor-Endued Repression of Lymphoma Migration and Prognosticates a Novel Proteomics-Based Subgroup of DLBCL through Its Negative Regulator IQGAP3Chih-Cheng Chen, Chia-Chen Hsu, Sung-Lin Chen, et al.
Steroids|March 22, 2016
Role of testosterone in regulating induction of TNF-α in rat spleen via ERK signaling pathwayChien-Wei Chen, Cai-Yun Jian, Po-Han Lin, et al.
Frontiers in Oncology|December 6, 2021
Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant TherapyPo-Han Lin, Ming-Yang Wang, Chiao Lo, et al.
Scientific Reports|February 2, 2020
Downregulation of testosterone production through luteinizing hormone receptor regulation in male rats exposed to 17α-ethynylestradiolPo-Han Lin, Tsung-Hsien Kuo, Chih-Chieh Chen, et al.
International Journal of Biological Sciences|December 21, 2016
Genes involved in angiogenesis and mTOR pathways are frequently mutated in Asian patients with pancreatic neuroendocrine tumorsWen-Chi Chou, Po-Han Lin, Yi-Chen Yeh, et al.
Journal of Human Genetics|January 27, 2012
Multimodel assessment of BRCA1 mutations in Taiwanese (ethnic Chinese) women with early-onset, bilateral or familial breast cancerWen-Hong Kuo, Po-Han Lin, Ai-Chu Huang, et al.
Journal of Surgical Oncology|September 3, 2013
Clinical and pathologic risk factors of tumor recurrence in patients with node-negative early breast cancer after mastectomyPo-Han Lin, Ming-Hsin Yeh, Liang-Chih Liu, et al.
Cancers|January 20, 2019
Varlitinib Downregulates HER/ERK Signaling and Induces Apoptosis in Triple Negative Breast Cancer CellsChun-Yu Liu, Pei-Yi Chu, Chun-Teng Huang, et al.
Angewandte Chemie (International Ed. in English)|May 23, 2024
Solid-Phase-Supported Chemoenzymatic Synthesis and Analysis of Chondroitin Sulfate Proteoglycan GlycopeptidesPo-Han Lin, Yongmei Xu, Semiha Kevser Bali, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|June 25, 2022
Neoadjuvant afatinib with paclitaxel for triple-negative breast cancer and the molecular characteristics in responders and non-respondersPo-Han Lin, Ling-Ming Tseng, Yi-Hsuan Lee, et al.
Pageof 9